Evidence Hub

Effects of polycystic ovary syndrome on liver, heart, muscle, and pancreatic-related diseases

Li B, Li Y, Li X, Yu Z, Yu J, Shao Y, Li T, Sun S et al.

Frontiers in endocrinology, 2026

Abstract

Background: PCOS is far more than an ovarian disorder; it is a systemic metabolic crisis affecting 11-13% of women. This review maps its extra-ovarian reach into the liver, heart, muscle, and pancreas.

Methods: We analyzed how the "pathophysiological quartet"-insulin resistance, hyperandrogenism, inflammation, and oxidative stress-coordinates systemic damage.

Results: PCOS prevalence skyrockets to 28.3% in women with obesity. Key findings include a 51.61% prevalence of MASLD in obese patients and a 2-4 fold increase in cardiovascular and type 2 diabetes risk. These manifestations are rooted in a shared metabolic "soil," creating a vicious cycle of androgen excess and multi-organ dysfunction, including sarcopenia and β-cell exhaustion.

Conclusion: Fragmented care is insufficient. The systemic nature of PCOS demands a paradigm shift toward integrated, multidisciplinary management, treating the patient as a metabolic whole.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free